PGNY Progyny

Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference

Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Michael Sturmer, Progyny’s President, will participate in a fireside chat at Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12, 2024 at 10:15 A.M. Eastern Time.

A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at

About Progyny

Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients and physicians. 

Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs. 

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Forbes’ Best Employers, Financial Times, Inc. 5000, Inc. Power Partners, and Crain’s Fast 50 for NYC. For more information, visit .

For Further Information, Please Contact:

Investors:

James Hart

Media:

Selena Yang



EN
11/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Progyny

 PRESS RELEASE

Progyny, Inc. Announces Second Quarter 2025 Results

Progyny, Inc. Announces Second Quarter 2025 Results Reports Record Revenue of $332.9 Million, Reflecting 9.5% GrowthGenerates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance to Reflect Continued Increase in Pacing of Member Engagement NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women's health and family building solutions, today announced its financial results for the three-month period ended June 30, 2025 (“the second quarter of 202...

 PRESS RELEASE

New Progyny Study Reveals Gap Between Perceptions and Realities in Wom...

New Progyny Study Reveals Gap Between Perceptions and Realities in Women’s Health Benefits Coverage Increased awareness of expanded women’s health and family building solutions has led to a growing disconnect between most wanted employee benefits and employer offerings NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the results of their new national research conducted in partnership with Dynata, the world’s largest first-party data company for insights, activation, and measurement...

 PRESS RELEASE

Progyny Partners with ŌURA to Empower Women and Their Care Teams with ...

Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced a new partnership with , maker of the world’s leading smart ring, further empowering women to better understand and take action on their health through comprehensive data and personalized insights. By incorporating wearable data and insights from ŌURA into the care team decision-support process—from p...

 PRESS RELEASE

Progyny, Inc. Provides Business Update and Announces Details for Its S...

Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report Operational and Financial Flexibility Enhanced Through New Credit FacilitySecond Quarter Results Anticipated to be Slightly Above Previously Provided Financial Guidance NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women's health and family building solutions, today announced that it has entered into a revolving credit facility (the “revolver” or the “facility”) which makes available to the Company up to $200 m...

 PRESS RELEASE

Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Ac...

Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women’s Health With nearly one third of women impacted by pelvic floor disorders, expanded care access and education from Progyny will help eliminate the silent suffering NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- , Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that it is adding to its comprehensive offering of women’s health and family building solutions. With the expansion of its network of specialty trained women’s health providers, and the addition of ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch